Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-05-23 Sale |
2023-05-23 5:19 pm |
Aurinia Pharmaceuticals Inc. | AUPH | Jayne David R.W. Director |
8,733 | $11.26 | $98,334 | 64,544 (Direct) |
View |
| 2023-05-19 Sale |
2023-05-23 5:18 pm |
Aurinia Pharmaceuticals Inc. | AUPH | Hagan Joseph P Director |
272 | $10.58 | $2,878 | 11,961 (Direct) |
View |
| 2023-05-23 Sale |
2023-05-23 5:17 pm |
Aurinia Pharmaceuticals Inc. | AUPH | Billen Daniel Director |
4,650 | $11.26 | $52,359 | 48,627 (Direct) |
View |
| 2023-05-23 Sale |
2023-05-23 5:16 pm |
Aurinia Pharmaceuticals Inc. | AUPH | MacKay-Dunn R. Hector Director |
4,818 | $11.26 | $54,251 | 39,459 (Direct) |
View |
| 2023-05-23 Sale |
2023-05-23 5:14 pm |
Aurinia Pharmaceuticals Inc. | AUPH | Leversage Jill Director |
4,815 | $11.26 | $54,217 | 33,762 (Direct) |
View |
| 2023-03-02 Purchase |
2023-03-06 4:29 pm |
Aurinia Pharmaceuticals Inc. | AUPH | MILNE GEORGE M JR Director |
20,000 | $8.9142 | $178,284 | 70,000 (Direct) |
View |
| 2023-03-02 Sale |
2023-03-06 4:29 pm |
Aurinia Pharmaceuticals Inc. | AUPH | Miller Joseph M Chief Financial Officer |
11,296 | $8.94 | $100,986 | 331,214 (Direct) |
View |
| 2023-03-02 Sale |
2023-03-06 4:29 pm |
Aurinia Pharmaceuticals Inc. | AUPH | Robertson Stephen P. EVP, General Counsel |
19,402 | $8.94 | $173,454 | 303,364 (Direct) |
View |
| 2023-03-02 Sale |
2023-03-06 4:27 pm |
Aurinia Pharmaceuticals Inc. | AUPH | Greenleaf Peter Chief Executive Officer |
32,750 | $8.94 | $292,785 | 982,968 (Direct) |
View |
| 2022-11-21 Purchase |
2022-11-23 4:04 pm |
Aurinia Pharmaceuticals Inc. | AUPH | Donley Matthew Maxwell Ex VP, Internal Operations |
10,000 | $4.66 | $46,600 | 27,927 (Direct) |
View |
| 2022-11-09 Purchase |
2022-11-14 4:31 pm |
Aurinia Pharmaceuticals Inc. | AUPH | Habig Scott Michael Chief Commercial Officer |
5,000 | $5.015 | $25,075 | 5,000 (Direct) |
View |
| 2022-11-07 Purchase |
2022-11-09 4:05 pm |
Aurinia Pharmaceuticals Inc. | AUPH | Martin Michael Robert Chief Business Officer |
30,000 | $5.16 | $154,800 | 89,512 (Direct) |
View |
| 2022-03-09 Purchase |
2022-03-11 4:05 pm |
Aurinia Pharmaceuticals Inc. | AUPH | MacKay-Dunn R. Hector Director |
5,000 | $11 | $54,985 | 11,000 (Direct) |
View |
| 2022-03-04 Purchase |
2022-03-08 4:06 pm |
Aurinia Pharmaceuticals Inc. | AUPH | MILNE GEORGE M JR Director |
5,000 | $10.82 | $54,100 | 50,000 (Direct) |
View |
| 2022-03-02 Sale |
2022-03-04 4:13 pm |
Aurinia Pharmaceuticals Inc. | AUPH | Martin Michael Robert Chief Business Officer |
4,849 | $12.01 | $58,236 | 228,798 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2023-09-21 Option Award |
2023-09-22 4:36 pm |
N/A N/A |
Aurinia Pharmaceuticals Inc. | AUPH | Foster Robert T Director |
53,283 | $0 | 53,283 (Direct) |
View |
| 2023-08-18 Option Award |
2023-08-21 4:25 pm |
N/A N/A |
Aurinia Pharmaceuticals Inc. | AUPH | Bailey Jeffrey Allen Director |
46,872 | $0 | 46,872 (Direct) |
View |
| 2023-08-18 Option Award |
2023-08-21 4:19 pm |
N/A N/A |
Aurinia Pharmaceuticals Inc. | AUPH | Smith Karen L. Director |
46,872 | $0 | 46,872 (Direct) |
View |
| 2023-05-18 Exercise |
2023-05-23 5:22 pm |
2023-05-18 N/A |
Aurinia Pharmaceuticals Inc. | AUPH | Balakrishnan Brinda Director |
8,733 | $0 | 33,277 (Direct) |
View |
| 2023-05-19 Option Award |
2023-05-23 5:22 pm |
N/A 2033-05-19 |
Aurinia Pharmaceuticals Inc. | AUPH | Balakrishnan Brinda Director |
24,544 | $0 | 33,277 (Direct) |
View |
| 2023-05-18 Exercise |
2023-05-23 5:19 pm |
2023-05-18 N/A |
Aurinia Pharmaceuticals Inc. | AUPH | Jayne David R.W. Director |
8,733 | $0 | 64,544 (Direct) |
View |
| 2023-05-19 Option Award |
2023-05-23 5:19 pm |
N/A 2033-05-19 |
Aurinia Pharmaceuticals Inc. | AUPH | Jayne David R.W. Director |
24,544 | $0 | 64,544 (Direct) |
View |
| 2023-05-18 Exercise |
2023-05-23 5:18 pm |
2023-05-18 N/A |
Aurinia Pharmaceuticals Inc. | AUPH | Hagan Joseph P Director |
8,733 | $0 | 11,961 (Direct) |
View |
| 2023-05-18 Exercise |
2023-05-23 5:17 pm |
2023-05-18 N/A |
Aurinia Pharmaceuticals Inc. | AUPH | Billen Daniel Director |
8,733 | $0 | 48,627 (Direct) |
View |
| 2023-05-19 Option Award |
2023-05-23 5:17 pm |
N/A 2033-05-19 |
Aurinia Pharmaceuticals Inc. | AUPH | Billen Daniel Director |
24,544 | $0 | 48,627 (Direct) |
View |
| 2023-05-18 Exercise |
2023-05-23 5:16 pm |
2023-05-18 N/A |
Aurinia Pharmaceuticals Inc. | AUPH | MILNE GEORGE M JR Director |
8,733 | $0 | 78,733 (Direct) |
View |
| 2023-05-18 Exercise |
2023-05-23 5:16 pm |
2023-05-18 N/A |
Aurinia Pharmaceuticals Inc. | AUPH | MacKay-Dunn R. Hector Director |
8,733 | $0 | 39,459 (Direct) |
View |
| 2023-05-19 Option Award |
2023-05-23 5:16 pm |
N/A 2033-05-19 |
Aurinia Pharmaceuticals Inc. | AUPH | MacKay-Dunn R. Hector Director |
24,544 | $0 | 39,459 (Direct) |
View |
| 2023-05-18 Exercise |
2023-05-23 5:14 pm |
2023-05-18 N/A |
Aurinia Pharmaceuticals Inc. | AUPH | Leversage Jill Director |
8,733 | $0 | 33,762 (Direct) |
View |
| 2023-05-19 Option Award |
2023-05-23 5:14 pm |
N/A 2033-05-19 |
Aurinia Pharmaceuticals Inc. | AUPH | Leversage Jill Director |
24,544 | $0 | 33,762 (Direct) |
View |
| 2023-03-02 Option Award |
2023-03-06 4:29 pm |
N/A N/A |
Aurinia Pharmaceuticals Inc. | AUPH | Donley Matthew Maxwell EVP, Ops & Strategy |
271,134 | $0 | 403,141 (Direct) |
View |
| 2023-03-02 Option Award |
2023-03-06 4:29 pm |
N/A N/A |
Aurinia Pharmaceuticals Inc. | AUPH | Miller Joseph M Chief Financial Officer |
229,421 | $0 | 331,214 (Direct) |
View |
| 2023-03-02 Option Award |
2023-03-06 4:29 pm |
N/A N/A |
Aurinia Pharmaceuticals Inc. | AUPH | Robertson Stephen P. EVP, General Counsel |
204,810 | $0 | 303,364 (Direct) |
View |
| 2023-03-02 Option Award |
2023-03-06 4:28 pm |
N/A N/A |
Aurinia Pharmaceuticals Inc. | AUPH | Martin Michael Robert Chief Business Officer |
107,202 | $0 | 259,162 (Direct) |
View |
| 2023-03-02 Option Award |
2023-03-06 4:28 pm |
N/A N/A |
Aurinia Pharmaceuticals Inc. | AUPH | Habig Scott Michael Chief Commercial Officer |
170,188 | $0 | 312,719 (Direct) |
View |
| 2023-03-02 Option Award |
2023-03-06 4:28 pm |
N/A N/A |
Aurinia Pharmaceuticals Inc. | AUPH | Knappertz Volker EVP, Research and Development |
191,462 | $0 | 344,274 (Direct) |
View |
| 2023-03-02 Option Award |
2023-03-06 4:27 pm |
N/A N/A |
Aurinia Pharmaceuticals Inc. | AUPH | Greenleaf Peter Chief Executive Officer |
667,407 | $0 | 982,968 (Direct) |
View |
| 2022-08-01 Option Award |
2022-08-01 4:13 pm |
N/A 2032-08-01 |
Aurinia Pharmaceuticals Inc. | AUPH | Knappertz Volker EVP, Research and Development |
409,704 | $0 | 409,704 (Direct) |
View |
| 2022-08-01 Option Award |
2022-08-01 4:13 pm |
N/A 2032-08-01 |
Aurinia Pharmaceuticals Inc. | AUPH | Habig Scott Michael Chief Commercial Officer |
368,734 | $0 | 368,734 (Direct) |
View |
| 2022-05-18 Exercise(A) |
2022-07-11 06:16 am |
N/A 2027-02-16 |
Aurinia Pharmaceuticals Inc. | AUPH | Jayne David R.W. Director |
10,000 | $0 | 40,000 (Direct) |
View |
| 2022-05-18 Exercise(A) |
2022-07-11 06:16 am |
N/A N/A |
Aurinia Pharmaceuticals Inc. | AUPH | Jayne David R.W. Director |
10,000 | $3.62 | 40,000 (Direct) |
View |
| 2022-05-18 Option Award |
2022-05-20 4:10 pm |
N/A N/A |
Aurinia Pharmaceuticals Inc. | AUPH | MILNE GEORGE M JR Director |
23,345 | $0 | 23,345 (Direct) |
View |
| 2022-05-18 Option Award |
2022-05-20 4:09 pm |
N/A N/A |
Aurinia Pharmaceuticals Inc. | AUPH | MacKay-Dunn R. Hector Director |
23,345 | $0 | 23,345 (Direct) |
View |
| 2022-05-18 Option Award |
2022-05-20 4:09 pm |
N/A N/A |
Aurinia Pharmaceuticals Inc. | AUPH | Billen Daniel Director |
23,345 | $0 | 23,345 (Direct) |
View |
| 2022-05-18 Option Award |
2022-05-20 4:09 pm |
N/A N/A |
Aurinia Pharmaceuticals Inc. | AUPH | Walbert Timothy P Director |
23,345 | $0 | 23,345 (Direct) |
View |
| 2022-05-18 Option Award |
2022-05-20 4:08 pm |
N/A N/A |
Aurinia Pharmaceuticals Inc. | AUPH | Jayne David R.W. Director |
23,345 | $0 | 23,345 (Direct) |
View |
| 2022-05-18 Option Award |
2022-05-20 4:08 pm |
N/A N/A |
Aurinia Pharmaceuticals Inc. | AUPH | Leversage Jill Director |
23,345 | $0 | 23,345 (Direct) |
View |
| 2022-05-18 Option Award |
2022-05-20 4:07 pm |
N/A N/A |
Aurinia Pharmaceuticals Inc. | AUPH | Balakrishnan Brinda Director |
23,345 | $0 | 23,345 (Direct) |
View |
| 2022-05-18 Option Award |
2022-05-20 4:07 pm |
N/A N/A |
Aurinia Pharmaceuticals Inc. | AUPH | Hagan Joseph P Director |
23,345 | $0 | 23,345 (Direct) |
View |
| 2022-03-02 Option Award |
2022-03-04 4:13 pm |
N/A N/A |
Aurinia Pharmaceuticals Inc. | AUPH | Martin Michael Robert Chief Business Officer |
177,786 | $0 | 228,798 (Direct) |
View |